The superior and inferior vena cava were snared with tapes. The pulmonary artery was separated from the ascending aorta with a sharp dissection. Following the cross-clamping of aorta, an aortotomy was performed and diastolic arrest was achieved by isothermic blood cardioplegia from the coronary ostia. Isothermic blood cardioplegia was used for myocardial protection and it was delivered continuously through retrograde route. The mitral valve was replaced with a 31 mm Omnicarbon bileaflet mechanical prosthesis and the posterior leaflet was preserved. The aortic annulus was narrow and it was enlarged with a glutaraldehyde-treated pericardial patch at the level of the non-coronary cusp (without dissecting the mitral annulus, the modified Nick’s procedure) and a 21 mm Omnicarbon bileaflet mechanical prosthesis was implanted in tilting position. The aortic cross-clamp was removed and a tricuspid valve Kay annuloplasty was performed on the beating heart. The patient was extubated four hours postoperatively. In her first day, 950 ml of hemorrhagic drainage was obtained from the mediastinal drain. In her second day, 650 ml of sero-hemorrhagic fluid was obtained. Later, the property of the drainage fluid was completely chylous and the patient was followed with a milky-white chylous drainage for 21 days, producing 330-750 ml of drainage daily (mean: 610 ml). The biochemical evaluation of the drainage fluid revealed triglyceride 789 mg/dl, protein 4.3 g/dl. In the microscopic evaluation, the leukocytes were detected with a domination of lymphocytes. The transthoracic echocardiographic examination revealed a mild pericardial effusion. The computerized tomographical (CT) analysis showed a hypodense collection around the thymus area (Fig. 1). Her diet was arranged as a high-protein one containing medium chained triglycerides in her first two weeks and the oral food intake was ceased and total parenteral nutrition was initiated in the third week. During this time, the total blood protein level had decreased from 6.8 g/dl to 5.5 g/dl, the lymphocyte count from 34% to 18% and the body weight had fallen from 53 kg to 48.5 kg. Since the patient did not respond to conservative measures, a revision operation was performed on the 21st day.
After the sternotomy, an elliptoid, gelatinous, 3x4 cm chylous collection was detected around the thymus. The probable drainage place was suspected to be the thymus tissue, which was sutured in a horse-shoe shape continuously with 4/0 polypropylene suture. Lymphatic drainage was excluded following the control of the aortic annulus, the inferior and superior vena cava areas. The pericardial edges were sutured continuously with 4/0 polypropylene and controlled for any leakages. The sternum was closed again with a drain left in the mediastinum. No pericardial collection was detected after the echocardiographic and radiographic evaluations and the patient was discharged one week after the revision operation. At the postoperative third month, she was completely normal in her physical and echocardiographic examination.
Chylopericardium occurs because of the inevitable damage to the small pericardial lymphatic ducts that drain into the thoracic duct later and/or the thymic intraglandular ducts during the operation. Leakage from the thymic tissue area occurs more commonly into the anterior mediastinum. Our patient had a major chylous collection around the thymic area that made it the possible mechanism of chylopericardium. We had also used a pericardial patch for the enlargement of the aortic root.
Less commonly, the chylopericardium develops from the posterior mediastinal tissues whilst passing the tape around the ascending aorta and the inferior and superior vena cava. We had controlled these areas and found no collection pointing to a source of lymphoid leakage. Another very rare cause of chylopericardium is an injury of the thoracic duct at its junction with the innominate vein during the central venous access to the left internal jugular or the left subclavian veins or a possible obstructing thrombus in these central veins.
Diagnosis and treatment approaches to the patients who develop a chylopericardium varies. The chylous pericardial fluid is a sterile, milky, odorless fluid containing microscopical fat droplets is alkaline with a density of 1010-1020 mg/dl.[7,8]
The CT assessment of the mediastinum and the detection of the collection with a fat density, the lymphangiographical localization of the thoracic duct and its relation with the pericardial lymphatics are the other important diagnostic methods for chylopericardium.[9,10]
The initial treatment of chylopericardium is a dietary modification (triglyceride diet with medium chained fatty acids) or total parenteral nutrition.[11] Also, somatostatin infusion has been shown to decrease the drainage.[12] Another management strategy of non-decreasing continuous leakage after three weeks is a pleuroperitoneal shunt operation.[13] For a few patients in whom the surgery is ineffective, a direct clipping of the thoracic duct either through a thoracotomy or a video-assisted thoracoscopic surgery may be performed.[14] Since there was a non-decreasing continuous leakage after three weeks of operation in our patient, we chose to perform an exploratory second surgical intervention.
In conclusion, chylopericardial effusions are potentially lethal postoperative complications. The ideal strategy for management is controlling the chylous effusion during the first operation. Electrocauterization or coagulation of the thin-walled lymphatic vessels may not be safe enough. This problem can be solved by a surgical ligation of the thymic vascular tissues. Chylopericardium is less common in heart surgery with sternotomy without entering the thoracal spaces. The management strategy for non-responding patients is a dietary modification, and later a total parenteral nutrition regimen within the first three weeks. An exploratory surgery is recommended in the cases with continued drainage after three weeks. Ligation of the thoracic duct is the final choice of treatment for nonresponding patients to the other strategies.
1) Papaioannou Y, Vomvoyannis A, Andritsakis G. Combined
chylopericardium and chylothorax after total correction of
Fallot’s tetralogy. Thorac Cardiovasc Surg 1984;32:115-6.
2) Bar-El Y, Smolinsky A, Yellin A. Chylopericardium as a complication
of mitral valve replacement. Thorax 1989;44:74-5.
3) Sharpe DA, Pullen MD, McGoldrick JP. A minimally invasive
approach to chylopericardium after coronary artery
surgery. Ann Thorac Surg 1999;68:1062-3.
4) Büttiker V, Fanconi S, Burger R. Chylothorax in children:
guidelines for diagnosis and management. Chest
1999;116:682-7.
5) Densupsoontorn NS, Jirapinyo P, Wongarn R, Thamonsiri N,
Nana A, Laohaprasitiporn D, et al. Management of chylothorax
and chylopericardium in pediatric patients: experiences
at Siriraj Hospital, Bangkok. Asia Pac J Clin Nutr. 2005;
14:182-7.
6) Eliskova M, Eliska O, Miller AJ. The lymphatic drainage of the
parietal pericardium in man. Lymphology 1995;28:208-17.
7) Akamatsu H, Amano J, Sakamoto T, Suzuki A. Primary
chylopericardium. Ann Thorac Surg 1994;58:262-6.
8) Bendayan P, Glock Y, Galinier M, Lesbordes JL, Fauvel JM,
Haguenauer G, et al. Idiopathic chylopericardium. Apropos
of a new case. Review of the literature. Arch Mal Coeur
Vaiss. 1991 Jan;84(1):127-30. [Abstract]
9) Svedjeholm R, Jansson K, Olin C. Primary idiopathic chylopericardium-
a case report and review of the literature. Eur J
Cardiothorac Surg 1997;11:387-90.
10) Kannagi T, Osakada G, Wakabayashi A, Kawai C, Matsuda
M, Miki S. Primary chylopericardium. Chest 1982;81:105-8.
11) Nguyen DM, Shum-Tim D, Dobell AR, Tchervenkov CI.
The management of chylothorax/chylopericardium following
pediatric cardiac surgery: a 10-year experience. J Card Surg
1995;10:302-8.
12) Rimensberger PC, Müller-Schenker B, Kalangos A, Beghetti
M. Treatment of a persistent postoperative chylothorax with
somatostatin. Ann Thorac Surg 1998;66:253-4.